sinan eliaçık

Dr. sinan eliaçık

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2021 in Neurological Research
Verified
Journal Article
Closed access
HOHalil Onder
Halil Onder
GGGurol Goksungur
Gurol Goksungur
SEsinan eliaçık
sinan eliaçık
EUErsin Kasim Ulusoy
Ersin Kasim Ulusoy
GAGüven Arslan
Güven Arslan
Background: The measurement of the optic nerve sheath diameter (ONSD) has been suggested to be used in the evaluation of intracranial pressure of several etiologies. However, its potential utility in the clinical evaluation of patients with idiopathic intracranial hypertension (IIH) needs to be clarified. Methods: We recruited all the IIH patients who had been admitted to our neurology clinics and had a cranial MRI before lumbar puncture investigation. A control group of patients with migraine was also included. Studies were reviewed blindly by a radiologist, and ONSD and ONSD/ eyeball transverse diameter (ETD) for both eyes were measured. Results: Ultimately, we have enrolled 50 patients with IIH and 53 migraineurs. The right ONSD values were higher in the IIH group (p = 0.024) whereas the values of ONSD/ETD were found to be both higher in the IIH group (right: p = 0.006, left: p = 0.043). The ROC curve demonstrated an area under the curve of 0.620 (95% CI = 0.508 to 0.731) for ONSD, and it was 0.642 for ONSD/ETD. Using a cut-off of 6.3 mm, ONSD had the following performance characteristics: sensitivity 18%, specificity 81%. Conclusions: The ONSD and ONSD/ETD values may be utilizable in the evaluation processes of IIH patients; however, they do not solely reach sufficient discriminative accuracy. The potential significance of these parameters in rather monitoring the IIH patients may constitute a strictly crucial topic of interest for future research.

3 July 2024 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
SEsinan eliaçık
sinan eliaçık
AKAyse Erdogan Kaya
Ayse Erdogan Kaya
Introduction and objective: Several studies revealed the therapeutic potential of vortioxetine (Vo) for pain. In this context, we aimed to evaluate the efficacy of Vo as a safe and tolerable novel pharmacologic agent in treating neuropathic pain (NP) in patients with major depressive disorder (MDD).Materials and methods: The population of this cross-sectional prospective study consisted of all consecutive patients who were newly diagnosed with MDD by a neurology doctor at a psychiatric clinic and had NP for at least 6 months. All patients included in the sample were started on Vo treatment at 10 mg/day. They were assessed with Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Self-Reported Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS), Douleur Neuropathique 4 Questions (DN4), Montreal Cognitive Assessment (MoCA), and Neuropathic Pain Impact on Quality of Life (NePIQoL) at the beginning of treatment and during the follow visits conducted at the end of the first, second and third months of the treatment. During these follow-up visits, patients were also queried about any side effects of Vo.Results: The mean age of 50 patients included in the sample, 76% of whom were female, was 45.8 ± 11.2 years. There was a significant reduction in patients’ NP complaints based on DN4 and S-LANNS, the subscales of NePIQoL, and significant improvement in MoCA. There was a significant reduction in patients’ NP complaints based on DN4 and S-LANNS scores and a significant improvement in scores of the subscales of NePIQoL and MoCA.Conclusion: The study’s findings indicate that Vo, with its multiple mechanisms of action, can effectively treat NP independently of its mood-stabilizing effect. Future indication studies for Vo are needed to establish Vo’s efficacy in treating NP.

31 December 2020 in International Neurourology Journal
Verified
Journal Article
Open access
PDF file
ABAykut BAŞER
Aykut BAŞER
SEsinan eliaçık
sinan eliaçık
MBMehmet Murat Baykam
Mehmet Murat Baykam
FTFunda Uysal Tan
Funda Uysal Tan
The aim of this study was to investigate the clinical manifestations of overactive bladder (OAB) with migraine as a comorbidity and to shed light on possible new treatment strategies. This study included patients aged 18 years and older who were admitted to urology and neurology outpatient clinics between March 1, 2019 and March 1, 2020 for OAB and migraine. The study questionnaire contained 3 sections: (1) questions on demographic characteristics, (2) a migraine ID test, and (3) the Overactive Bladder Inquiry Form - V8 (OAB-V8) form. A total of 265 patients participated in the study. The average age of the participants was 39.75±11.93 years. The patients were divided into 3 groups according to the coexistence of OAB with migraine: group 1, OAB(+)/migraine(+); group 2, OAB(+)/migraine(-); and group 3, OAB(-)/migraine(+). The mean OAB-V8 score was 22.82 ±8.15 in group 1 and 25.64±7.49 in group 2. The mean OAB-V8 score of OAB patients with migraine as a comorbidity was statistically significantly lower than that of OAB patients without migraine (P=0.015). The median visual analogue scale (VAS) score was 7.11 (range, 2-10) in group 1 and 5.95 (range, 2-10) in group 3. This finding indicates that in patients with migraine, having OAB was associated with significantly higher VAS scores (P<0.001). OAB and migraine may be comorbid conditions coexisting in a single patient. This comorbidity may lead to a lower perception of OAB symptoms in OAB patients or, conversely, to a higher perception of migraine pain. Further studies are needed to elucidate how treatments for each of these diseases can affect the other disease.

1 January 2019 in Annals of Indian Academy of Neurology
Verified
Journal Article
Open access
SEsinan eliaçık
sinan eliaçık
ÖSÖmerönder Savas
Ömerönder Savas
EKErdal Komut
Erdal Komut
FTFundaUysal Tan
FundaUysal Tan

1 September 2018 in Interventional Medicine and Applied Science
Verified
Journal Article
Open access
OKOsman Karaarslan
Osman Karaarslan
MKMacit Kalçık
Macit Kalçık
VÇVolkan Çamkıran
Volkan Çamkıran
SEsinan eliaçık
sinan eliaçık
ÇAÇağlar Alp
Çağlar Alp
YKYusuf Karavelioğlu
Yusuf Karavelioğlu
ST-elevation myocardial infarction (STEMI) due to septic coronary embolism is a rare complication of infective endocarditis (IE) and is associated with high mortality rates. When common signs of IE are often overlooked on admission, the diagnosis may be established through complications, which may cause prominent symptoms. Here, we report a case of native mitral valve endocarditis with an unusual presentation with STEMI and concomitant ischemic stroke, which was due to multiple coronary and cerebral septic embolisms.

1 January 2024 in Biomedical Human Kinetics
Verified
Journal Article
Open access
PDF file
ÖDÖzlem Dündar
Özlem Dündar
SCSema Can
Sema Can
SEsinan eliaçık
sinan eliaçık
TYTurgut Yıldırım
Turgut Yıldırım
Study aim : Migraine is a headache syndrome that may occur in all age groups. The purpose of this study was to examine the effects of hatha yoga (HY) exercises on pain in migraine patients. Material and methods : Volunteer individuals aged 18–55, diagnosed with chronic migraine (n = 32; experimental group n = 15; control group n = 17) were included in this study (mean age of the experimental and control groups, respectively: 35.80 ± 7.78 years; 36.65 ± 9.62 years). The HY exercise program was planned for 12 weeks, 3 days a week, 30–90 minutes. Anthropometric measurements, the Visual Analogue Scale (VAS), the Headache Impact Test (HIT-6), and the Migraine Disability Assessment Questionnaire (MIDAS) were used. Measurements were carried out in three different time periods. Results : There was a clinically significant decrease in the VAS, HIT-6, and MIDAS values measured at different times in the experimental group. The third measurement values were lower than the first measurement in the experimental group (p = 0.001). A significant difference was found between the third measurement values of VAS and HIT-6 values in the experimental and control groups (respectively p = 0.014; p = 0.005). Conclusions : The results suggest that HY exercises have a positive effect in migraine patients on pain intensity, frequency and number of days lost due to pain. In our opinion, HY exercises can be recommended as a complementary treatment in migraine patients.